Welcome to GENESIS Hangzhou!

page_banner

news

New Arrival | KaiBiLi COVID-19 Neutralization Ab+ Rapid Test Helps to Immunity Detection

 

Globally, the number of COVID-19 new cases increased markedly in the past week (3-9 January 2022), while the number of new deaths remained similar to that of the previous week. Across the six regions, over 15 million new cases were reported this past week, a 55% increase as compared to the previous week and over 43,000 new deaths were reported.

微信图片_20220114161220

Data from WHO COVID-19 Weekly Epidemiological Update, published 11 January 2022

Vaccines save millions of lives each year. Vaccines work by training and preparing the body’s natural defences – the immune system – to recognize and fight off the viruses and bacteria they target. After vaccination, if the body is later exposed to those disease-causing germs, the body is immediately ready to destroy them, preventing illness. Vaccination is one crucial part of managing COVID-19, getting vaccinated as soon as it’s your turn and follow local guidance on vaccination is strongly advised by WHO.

Have you ever detected the efficacy after the vaccination against COVID-19?

How high do antibody titres have to be in order to be protected from COVID-19 infection after a corona vaccination?

Are you looking for a quick and easy way to get the antibody titre results to guide a booster vaccination?

SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M) and nucleocapsid (N). The spike protein (S) contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor, angiotensin converting enzyme-2 (ACE2). It is found that the RBD of the SARS-CoV-2 spike protein strongly interacts with the human ACE2 receptor leading to endocytosis into the host cells of the deep lung and viral replication. Infection with the SARS-CoV-2 or vaccination initiates an immune response, which includes the production of anti-RBD IgG antibody in the blood. The secreted antibody provides protection against future infections from viruses, because it remains in the circulatory system for months to years after infection or vaccination and will bind quickly and strongly to the pathogen to block cellular infiltration and replication. 

According to a recent research from the University of Oxford, an 80 percent protective effect against symptomatic infection with of SARS-CoV-2 is achieved with 506 binding antibody units (BAU)/ml of IgG antibodies directed against the RBD proteins.

KaiBiLi COVID-19 Neutralization Ab+ Rapid Test is a lateral flow chromatographic immunoassay for the semiquantitative detection of anti-RBD IgG antibody to SARS-CoV-2 in human whole blood, serum or plasma specimen. The device can detect the concentrations of anti-RBD IgG antibody greater than or equal to 506 BAU/mL as effective antibody concentration and 5 BAU/mL as limit of detection.

微信图片_20220111145238

      Features

       Simple to use, affordable, and self-administered;

       Delivering result within 15 minutes;

       No equipment required with minimal operation;

       Various specimen types applicable;

       Semi-quantitative with high specificity.

 

 

 

ORDERING INFORMATION

Product

Cat.No.

Specification

KaiBiLi COVID-19 Neutralization Ab+ Rapid Test

P231145

40 Tests

 


Post time: Jan-14-2022